Status:
COMPLETED
Lymphocyte Immunophenotyping in Common Variable Immunodeficiency
Lead Sponsor:
Barts & The London NHS Trust
Conditions:
Common Variable Immunodeficiency
Granulomatous Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to discover if differences in the surface markers of B-cells (antibody producing cells of the immune system) in Common Variable Immune Deficiency (CVID) are related to CVI...
Detailed Description
Common Variable Immune Deficiency (CVID) is a syndrome containing a spectrum of disorders which results in weakened immunity and recurrent infections. The ESID (European Society for Immunodeficiencies...
Eligibility Criteria
Inclusion
- 18 or over
- Competent to consent
- Have diagnosis of Common Variable Immunodeficiency, granulomatous disease, on long term immunoglobulin or bronchiectasis.
Exclusion
- Under 18
- Unable to consent.
- Medical problem that could alter B-cell immunophenotype (except for the diagnoses in the inclusion criteria)/
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01196702
Start Date
September 1 2020
End Date
December 30 2023
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts and the London NHS Trust
London, United Kingdom, E1 1BB